"We are proud of our 136-year ministry and our commitment to the people of Pueblo, our surrounding communities and our Catholic health ministry."
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
136
Alliance for Clinical Trials in Oncology
66
SWOG Cancer Research Network
40
ECOG-ACRIN Cancer Research Group
23
Eastern Cooperative Oncology Group
23
NSABP Foundation Inc
10
Radiation Therapy Oncology Group
7
NRG Oncology
5
GOG Foundation
3
Gynecologic Oncology Group
3
Wake Forest University Health Sciences
3
Clinical Trials at Saint Mary Corwin Medical Center
During the past decade, Saint Mary Corwin Medical Center conducted 119 clinical trials. In the 10-year time frame, 119 clinical trials started and 148 clinical trials were completed, i.e. on
average, 124.4% percent of trials that started reached the finish line to date. In the past 5 years, 33 clinical trials started and 54 clinical trials were completed. i.e. 163.6%
of trials that started reached the finish line.
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
1999-04-01
2016-05-01
Completed
854
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Saint Mary Corwin Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 136 trials, followed by "Alliance for Clinical Trials in Oncology" with 66 trials
sponsored, "SWOG Cancer Research Network" with 40 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 23 trials sponsored and "Eastern Cooperative Oncology Group"
with 23 trials sponsored. Other sponsors include 35 different institutions and
companies that sponsored additional 19 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Mary Corwin Medical Center"
#1 collaborator was "National Cancer Institute (NCI)" with 188 trials as a collaborator, "NRG Oncology" with 27 trials as a collaborator, "SWOG Cancer Research Network" with 16 trials as a collaborator, "Cancer and Leukemia Group B" with 14 trials as a collaborator and "NCIC Clinical Trials Group" with 11 trials as a collaborator. Other collaborators include 58 different institutions and companies that were
collaborators in the rest 43 trials.
Clinical Trials Conditions at Saint Mary Corwin Medical Center
According to Clinical.Site data, the most researched conditions in "Saint Mary Corwin Medical Center" are
"Breast Cancer" (26 trials), "Lung Cancer" (13 trials), "Lymphoma" (13 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (13 trials) and "Recurrent Breast Carcinoma" (12 trials). Many other conditions were trialed in "Saint Mary Corwin Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at Saint Mary Corwin Medical Center
Most popular intervention types in "Saint Mary Corwin Medical Center" are "Drug" (272 trials), "Other" (169 trials), "Biological" (143 trials), "Procedure" (57 trials) and "Radiation" (45 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (81 trials), "Quality-of-Life Assessment" (56 trials), "Paclitaxel" (36 trials), "Carboplatin" (32 trials) and "Questionnaire Administration" (32 trials). Other intervention names were less common.
Clinical Trials Genders at Saint Mary Corwin Medical Center
The vast majority of trials in "Saint Mary Corwin Medical Center" are
262 trials for "All" genders, 53 trials for "Female" genders and 13 trials for "Male" genders.
Clinical Trials Status at Saint Mary Corwin Medical Center
Currently, there are NaN active trials in "Saint Mary Corwin Medical Center".
undefined are not yet recruiting,
58 are recruiting,
114 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 130 completed trials in Saint Mary Corwin Medical Center,
2 suspended trials,
and 20 terminated clinical trials to date.
Out of the total trials that were conducted in Saint Mary Corwin Medical Center, 6 "Phase 1"
clinical trials were conducted, 149 "Phase 2" clinical
trials and 172 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 7 trials that are defined as “Not Applicable".